Phase II Study of Nimotuzumab Plus PF as Induction Chemotherapy in Patients With Locally Advanced HNSCC.

Trial Profile

Phase II Study of Nimotuzumab Plus PF as Induction Chemotherapy in Patients With Locally Advanced HNSCC.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2012

At a glance

  • Drugs Nimotuzumab (Primary) ; Cisplatin; Fluorouracil
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jan 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 05 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top